Lilly Endowment Files Form 144 to Sell $347M in Eli Lilly Shares

Executive Summary

On October 7, 2026, Lilly Endowment, Inc. filed a Form 144 notice disclosing an intention to sell 300,000 shares of Eli Lilly & Co ($LLY) Common Stock through J.P. Morgan Securities LLC. The proposed transaction carries an estimated aggregate market value of $347,247,000, representing an implied share price of approximately $1,157.49.

Transaction Details

• Security: Common Stock
• Shares Proposed for Sale: 300,000
• Aggregate Market Value: $347,247,000
• Shares Outstanding: 941,357,065 (~0.03% of outstanding shares)
• Original Acquisition: Acquired via gift on February 10, 1948, from the J.K. Lilly Sr. Trust.
• Recent Prior Activity (Past 3 Months):
  • 07/07/2026: 80 shares ($99,200)
  • 07/08/2026: 7,395 shares ($9,172,695.88)
  • 08/13/2026: 122 shares ($151,280)
  • 08/19/2026: 302,403 shares ($385,708,676.04)

Market & Strategic Impact

While a $347M block is substantial in absolute dollar terms, it constitutes only 0.03% of Eli Lilly's 941.36 million outstanding shares. Lilly Endowment periodically executes large sales of Lilly stock to support its ongoing charitable grantmaking and rebalance its philanthropic endowment assets. Investors typically view these planned periodic sales by the Endowment as routine programmatic divestments rather than a shift in fundamental sentiment regarding company prospects.